Genes may predict response to diabetes drug

	Tweet

How well a person with type 2 diabetes responds to the anti-diabetes drug rosiglitazone (Avandia) may depend upon his or her genetic make-up.

Korean researchers have observed that type 2 diabetic patients with certain genetic variations in the adiponectin gene respond less favorably to Avandia treatment than do those who carry other genotypes. Adiponectin is a protein that is secreted by fat cells and is involved in regulating food intake and body weight.

The study, reported in the May issue of the journal Diabetes Care, joins a growing body of research focused on pharmacogenetics, that is how genetic factors influence a person’s reaction to a specific drug.

In the study, Dr. Eun Seok Kang of Yonsei University School of Medicine in Seoul and colleagues studied 166 patients with type 2 diabetes who were treated with (Avandia) for 12 weeks.

“We found that variations in the adiponectin gene could affect the (Avandia) treatment response to the serum adiponectin level and blood glucose control,” Kang told Reuters Health.

Compared with patients with other genotypes, carriers of the so-called GG genotype of the single nucleotide polymorphism (SNP) 45 of the adiponectin gene had a smaller reduction in fasting plasma glucose levels and HbA1c values, a measure of excess blood sugar. They also had a significantly smaller increase in blood adiponectin concentration.

Likewise, carriers of the GG genotype of SNP276 also showed less reduction in fasting glucose levels than did other patients.

These findings, the researchers say, might help doctors predict which patients will respond best to Avandia treatment. “Obviously knowing ahead of time which drugs will work best means we can eliminate the entire trial-and-error process of drugs that don’t work or work poorly for some people,” Kang said.

“Clearly we have a lot more to learn before we get to that stage, but this is an important first step.”

SOURCE: Diabetes Care May 2005. 

RELATED STORIES:
Diabetes linked to reduced risk of prostate cancer   Skipping diabetes meds ups risk of hospitalization   2 tests better than 1 to diagnose diabetes in overweight children   Immune therapy stops diabetes in mouse study   Britons at risk of diabetes know little of disease   Treating Gum Disease Linked to Lower Medical Costs for Patients with Diabetes   Researchers Discover New Effect for Insulin   Low vitamin D linked to the metabolic syndrome in elderly people   Einstein researchers find link between brain molecule and obesity and diabetes   Achilles surgery may not help function in diabetes   Milk and Dairy Products Protect Against “Metabolic Syndrome”   Glucose not sole risk for diabetic nerve problem

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]